Journal profile · ENDOCRINOLOGY & METABOLISM-PEDIATRICS
Hormone Research in Paediatrics
ISSN 1663-2818 · eISSN 1663-2826 · S. Karger AG · SWITZERLAND · Monthly · Founded 2010
Hormone Research in Paediatrics: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.7; hybrid open access; median 98 days to acceptance (101 articles, last 24 months); community-reported acceptance: fairly easy; 145 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Hormone Research in Paediatrics is published by S. Karger AG and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Growth Hormone and Insulin-like Growth Factors, Sexual Differentiation and Disorders and Human auditory perception and evaluation, together about 30.2% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
The mission of Hormone Research in Paediatrics is to improve the care of children with endocrine disorders by promoting basic and clinical knowledge. The journal facilitates the dissemination of information through original papers, mini-reviews, clinical guidelines or novel insights from clinical practice, and abstracts from international congresses in pediatric endocrinology.
From the journal's Aims & Scope
Research area (LetPub): ENDOCRINOLOGY & METABOLISM-PEDIATRICS
Editor-in-chief Stefano CianfaraniPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Growth Hormone and Insulin-like Growth FactorsMedicine16.3%
- Sexual Differentiation and DisordersBiochemistry, Genetics and Molecular Biology7.7%
- Human auditory perception and evaluationEngineering6.2%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance6.1%
- Pituitary Gland Disorders and TreatmentsMedicine5.6%
- Birth, Development, and HealthMedicine5.3%
- Thyroid Disorders and TreatmentsMedicine5.2%
- Hypothalamic control of reproductive hormonesMedicine4.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pediatrics | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
| Minor | Pediatrics | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pediatrics | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.7LetPub ·
- Impact factor (publisher)
- 3.8Publisher website ·
- CiteScore 2026-06
- 7.2LetPub ·
- CiteScore (publisher)
- 7.2Publisher website ·
- SJR 2026-06
- 1.04LetPub ·
- SNIP 2026-06
- 1.43LetPub ·
- h-index
- 82LetPub ·
- h-index
- 117OpenAlex ·
- i10-index
- 2,482OpenAlex ·
- 2-year mean citedness
- 3.18OpenAlex ·
- Self-citation rate
- 2.6%LetPub ·
- Share of gold OA articles
- 27.02%LetPub ·
Volume
- Articles per year
- 115LetPub ·
Articles by year OpenAlex count · 4,596 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 86 | 44 | 19 |
| 2025 | 145 | 77 | 269 |
| 2024 | 123 | 73 | 838 |
| 2023 | 100 | 51 | 601 |
| 2022 | 124 | 60 | 1,444 |
| 2021 | 104 | 48 | 1,389 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
98 daysMedian, submission to acceptance · P25–P75 69 days – 140 days
- Acceptance to online
- median 20 days (101 articles)
- Submission to online
- median 124 days
- Sample
- 101 articles with submission and acceptance dates (354 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Acceptance rate (publisher)
- 32.1%Publisher website ·
- Submission to final decision
- 39 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- S. Karger AG
- Country or region
- SWITZERLAND
- Language
- English
- Frequency
- Monthly
- Founded
- 2010
- ISSN
- 1663-2818
- Electronic ISSN
- 1663-2826
- Latest issue on the website
- Volume 99, Issue 5 (July 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Hormone Research in Paediatrics
What CAS zone is Hormone Research in Paediatrics in?
In the 2025 upgraded edition of the CAS Journal Ranking, Hormone Research in Paediatrics is in Zone 3 of Medicine, and in Zone 3 of the minor category Pediatrics / Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Hormone Research in Paediatrics?
The latest impact factor listed by LetPub is 3.7; CiteScore 7.2, h-index 117.
How long does peer review take at Hormone Research in Paediatrics?
Based on the dates recorded on 101 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 98 days (interquartile range 69–140 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Fairly easy”; the journal's website gives an acceptance rate of 32.1%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Hormone Research in Paediatrics?
According to LetPub and DOAJ records, Hormone Research in Paediatrics is indexed in SCIE and Scopus.
Is Hormone Research in Paediatrics open access, and what is the APC?
Hormone Research in Paediatrics is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .